← All Blogs
Market Trends February 13, 2026

The Healthtech Opportunity: Could NHCX Create India's Next ₹80,000 crore Ecosystem?

Could NHCX do for healthcare claims what UPI did for payments? An analysis of the $15B market opportunity, five emerging business layers, and whether 2025-2027 represents the critical window for NHCX-native companies.

As UPI spawned PhonePe and revolutionized payments, India’s new health claims infrastructure has the potential to create its own ecosystem of winners, if it can replicate even a fraction of that success

The UPI Playbook: A Template, Not a Guarantee

In December 2024, Indians processed 1,673 crore (16.73 billion) UPI transactions worth ₹23.25 lakh crore. PhonePe alone, which didn’t exist before UPI’s 2016 launch, now commands 47.7% market share and posted ₹5,064 crore in revenue for 2024, a 74% year-on-year jump.

The pattern is well documented: when government builds open digital infrastructure, private innovation can explode on top of it. UPI created payment unicorns. The question facing healthtech investors and founders today is whether the same dynamic could play out in healthcare claims.

The National Health Claim Exchange (NHCX), launched operationally in mid-2024, isn’t just digitizing insurance paperwork. It’s infrastructure; open, standardized digital rails that multiple businesses could build upon. According to IMARC, the India revenue cycle management (RCM) market was about $4.8 billion in 2024 and is projected to reach $15 billion by 2033 (12.6% CAGR), with Ken Research publishing similar but slightly more conservative base estimates around $4 billion.

Whether NHCX spawns the next PhonePe remains an open question. But early signals suggest a similar ecosystem dynamic may be beginning to emerge.

What Is Confirmed vs. What Is Inferred

CONFIRMED (Government & Company Sources):

DIRECTIONALLY CONFIRMED (Multiple Research Firms, Specific Figures Vary):

INFERRED (Analysis & Projections):

The Friction That Could Build a Market

According to a July 2024 Ministry of Health and Family Welfare press release, 34 insurers and third-party administrators (TPAs) had gone live on NHCX as of mid-2024, with approximately 300 hospitals ramping up operations at that time. These numbers reveal more than adoption rates, they expose what could become a massive market opportunity.

To put this in perspective: India’s non-life health insurance sector collected ₹1,17,000 crore (~$14 billion) in gross written premium in FY2024, with approximately 87% flowing toward claims settlement. The RCM software and services market, which manages the entire revenue cycle from patient eligibility verification through claims processing to payment posting, is currently valued at $4.8 billion, representing the addressable market for solution providers.

As of early 2026, NHCX is gaining regulatory momentum: the government moved the platform under joint Finance Ministry-IRDAI supervision in mid-2025 to combat inflated hospital costs and strengthen pricing transparency. Meanwhile, major insurers including HDFC Ergo and Reliance General have begun processing actual claims on NHCX, albeit at small scale, marking the transition from pilot to operational infrastructure.

For years, India’s health insurance ecosystem has operated through what industry insiders call “islands of automation.” Hospitals built sophisticated billing systems. Insurers launched digital portals. Yet these systems couldn’t talk to each other. A hospital dealing with ten different insurers meant navigating ten different portals, each with unique formats, submission requirements, and reconciliation processes.

The result: persistent operational friction. Hospitals face receivable cycles stretching weeks or months. Staff spend hours on administrative follow-ups instead of patient care. Insurers grapple with high processing costs and persistent fraud detection challenges.

As Tapan Singhel, MD and CEO of Bajaj General Insurance, noted in June 2024, while all major insurers have onboarded to NHCX, slow hospital participation remains a bottleneck hindering the system’s full potential for faster, simpler, and more transparent cashless treatments.

That bottleneck and the solutions emerging to address it, is where entrepreneurs are beginning to place their bets.

The Infrastructure Play: Digital Rails for Claims

NHCX doesn’t process or adjudicate claims. Like UPI, it’s infrastructure is a standardized communication protocol that providers and payers use to exchange information securely.

The architecture parallels UPI’s approach: Hospitals encrypt claim details and send requests to the NHCX gateway. The gateway validates formatting, records transactions for auditing, and routes encrypted packages to the correct payers. Payers process claims and send encrypted responses back. The gateway never sees the contents; it’s a secure postman, not a data warehouse.

All data flows through FHIR (Fast Healthcare Interoperability Resources), a globally recognized standard that ensures information is structured consistently and machine-readable. This matters because standardized, structured data is the raw material for automation, analytics, and AI, the very tools that could power a new generation of healthtech companies.

The key parallel to UPI: NHCX solves the “connect once, reach everyone” problem that has plagued healthcare IT for decades. A hospital integrating with NHCX can potentially communicate with all participating insurers through a single technical connection.

But the comparison has limits. Healthcare claims are fundamentally more complex than payments. UPI benefited from a clear consumer use case (send money instantly), obvious network effects (everyone needed it), and zero transaction fees. NHCX faces longer sales cycles, requires specialized technical integration expertise, and operates in a heavily regulated sector with slower adoption dynamics.

The question isn’t whether NHCX will automatically replicate UPI’s trajectory. It’s whether the similar infrastructure model creates comparable opportunities for innovation.

Early Signals: Five Layers of Opportunity

The businesses attempting to build on NHCX’s infrastructure are already emerging across five distinct layers:

Layer 1: Integration-as-a-Service

Integration service providers are emerging as the “picks and shovels” providers, offering AI-powered claims automation and NHCX compliance services to insurers and TPAs. Several providers have completed M1 ABDM integration for major hospital chains and have presented integration solutions at industry workshops attended by hundreds of participants.

The potential: Every hospital needs NHCX integration, but most lack the IT resources to build it themselves. That’s 300 hospitals as of mid-2024, potentially thousands in coming years; if adoption accelerates.

Layer 2: Revenue Cycle Management (RCM)

Multiple market research firms project significant growth in India’s healthcare RCM market. IMARC Group estimates the market at $4.8 billion in 2024, growing to approximately $15 billion by 2033 (roughly 12.6% CAGR). Ken Research provides similar market sizing with higher growth projections. While specific CAGR figures vary by research methodology, the consensus direction is clear: India’s RCM market represents a multi-billion dollar opportunity over the next decade.

NHCX standardization could accelerate this growth by reducing manual work and enabling automation, though actual outcomes will depend on adoption rates.

Several service providers have launched RCM-as-a-Service offerings and AI-powered RCM platforms specifically for the Indian market. Their revenue models are outcomes-based: they take a percentage of successfully collected claims.

Globally, service providers have raised significant funding to deploy AI agents for denial management, a problem that persists at 10-15% denial rates even in mature markets. NHCX’s standardized data could create the foundation for similar solutions in India, if the data volumes reach critical mass.

Layer 3: Analytics and Fraud Detection

If NHCX achieves widespread adoption, India would have standardized, machine-readable claims data flowing at national scale for the first time. This could create opportunities for:

The potential moat: First movers might accumulate proprietary datasets that become increasingly valuable as network effects compound, the same dynamic that gave UPI players data advantages. But this depends entirely on transaction volumes scaling significantly.

Layer 4: Fintech and Embedded Finance

Standardized claims data could enable new financing models. Hospitals with pending claims might access working capital loans. Invoice discounting could become viable. Revenue-based financing products might emerge, using RCM data as underwriting criteria.

For patients, point-of-care medical loans and insurance premium financing could become possible when claims processing is predictable and transparent. To support early adoption, the government’s Digital Health Incentive Scheme offers ₹500 per claim or 10% of the claim amount (whichever is lower) to encourage participation.

Layer 5: Consulting, Training, and Compliance

There’s a documented skills gap. FHIR expertise is scarce. Healthcare IT integration specialists are in demand. Navigating NHCX compliance requires specialized knowledge.

Training programs, integration consulting, and compliance-as-a-service businesses are already emerging to fill these gaps, representing a more immediate, lower-risk opportunity than building platform businesses that depend on mass adoption.

Who’s Positioned to Place Early Bets

The early signals point to three types of potential winners:

The Infrastructure Builders: The Infrastructure Builders: Integration service providers are the “picks and shovels” of this potential gold rush. They could benefit regardless of which specific use case dominates, as long as hospitals and insurers continue integrating with NHCX.

The Data Aggregators: Companies that can accumulate and analyze NHCX transaction data across multiple hospitals and insurers might build defensible moats, if they can navigate privacy regulations and achieve the data volumes necessary to create meaningful insights.

The RCM Specialists: With a market projected to grow at 17% annually and government incentives encouraging early adoption, RCM platforms have clear tailwinds. But success depends on solving real operational problems, not just riding the NHCX wave.

According to Tracxn data, India has over 12,000 healthtech startups, with roughly 1,600 having raised institutional funding, and approximately 300 at Series A or beyond stages. If NHCX does catalyze ecosystem growth, it could create the next cohort of breakout companies, but that’s a projection, not a certainty.

Lessons from UPI and Why They Might Not Apply

What made PhonePe and Google Pay successful on UPI infrastructure offers potential lessons for NHCX entrepreneurs:

Lesson 1: Infrastructure reliability beats features. PhonePe’s early obsession with 99.99% uptime and transaction reliability mattered more than flashy features. For NHCX, protocol compliance and system stability would be table stakes.

Lesson 2: Network effects can compound fast. PhonePe didn’t just serve consumers or merchants; they served both, creating a two-sided network. NHCX businesses might need to think about serving hospitals AND insurers, or insurers AND patients.

Lesson 3: B2B2C models can scale faster. PhonePe partnered with banks to distribute services. In healthcare, enabling hospitals to better serve patients through NHCX could create similar leverage.

Lesson 4: Data moats emerge over time. UPI players’ transaction data advantages became competitive moats. Early NHCX data aggregation might be similarly valuable, if volumes materialize.

Lesson 5: Timing can matter more than perfection. PhonePe launched UPI services before the product was perfect. In the NHCX ecosystem, being early might matter more than being polished.

But here’s why the parallel might not hold: Healthcare is more complex than payments. UPI’s consumer value proposition was immediate and obvious. NHCX’s benefits are largely operational, accruing to administrators rather than end-users. Adoption depends on hospital IT capabilities and willingness to change workflows, not just consumer behavior. The network effects are less direct, a hospital doesn’t gain immediate value from another hospital joining NHCX the way a UPI user benefits from more merchants accepting payments.

The Risks: What Could Prevent the Ecosystem from Materializing

Several factors could prevent NHCX from catalyzing the ecosystem growth that UPI achieved:

Hospital adoption lag: As Bajaj General Insurance’s CEO noted in June 2024, slow hospital participation is the current bottleneck. If the 300 hospitals that were ramping up as of mid-2024 don’t reach critical mass by 2026-2027, network effects won’t materialize and the business case for ecosystem players weakens significantly.

Regulatory complexity: Healthcare regulation is intricate and evolving. New compliance requirements or data privacy rules could increase integration costs or limit data usage for analytics, making business models unviable.

Technical implementation challenges: FHIR is not trivial to implement correctly. Poor integrations could create claims processing errors that undermine trust in the system, slowing adoption and limiting the addressable market.

Market fragmentation: Unlike UPI, where standardization was immediate and universal, healthcare has more complexity. Different specialties, procedures, and insurance products may require custom handling that limits automation benefits and reduces the scope for winner-take-all dynamics.

Funding environment: While H1 2025 healthtech funding showed strong recovery to $828M, full-year data suggests the sector still faces headwinds, though specific figures vary by source and methodology. While 91% of investors surveyed by Inc42 express optimism about 2025, capital constraints could slow startup formation precisely when the market opportunity might be emerging.

The UPI comparison itself: UPI succeeded in part because of massive consumer adoption driven by demonetization and zero transaction fees. NHCX lacks such forcing functions and operates in B2B2C markets with longer sales cycles. The infrastructure might be similar, but the adoption dynamics are fundamentally different.

The Verdict: A Window of Opportunity-If Conditions Align

The opportunity may exist, but it depends on several conditions aligning over the next 2-3 years.

Here’s the bull case for why 2025-2027 could matter: It may be a Goldilocks zone. Too early, in 2023 when NHCX was just sandbox testing and the infrastructure wasn’t ready. Too late, by 2028-2029 when established hospital information system vendors will likely have added NHCX modules and the market could be saturated.

As of late 2024 and through 2027, three conditions are beginning to align:

  1. Infrastructure is operational: 34 insurers and 300 hospitals were live as of July 2024 (latest available government data); actual current participation may be higher, creating real transaction volume
  2. Pain points are still acute: The manual claims process is prevalent enough that automation could provide dramatic value
  3. Competition is nascent: The market hasn’t consolidated around dominant players

The UPI parallel is instructive about timing. PhonePe launched in 2016, the same year UPI went live. By 2018, they had achieved market leadership. By 2020, their position was difficult to challenge. The window for new UPI apps to gain meaningful share had largely closed.

If NHCX follows a similar trajectory, we’re at the 2016-2017 equivalent moment as of late 2024/early 2025. But that’s a significant “if.”

For founders, the calculation involves risk assessment: Multiple market research firms project India’s RCM market will grow by approximately $10 billion over the next decade, from roughly $4.8B to $15B.

Scenario-based addressable market estimates:

But realizing any of these scenarios depends on NHCX achieving adoption rates that remain highly uncertain.

For VCs, the thesis is similarly nuanced: While H1 2025 healthtech funding showed recovery to $828M (up from $233.5M in H1 2024), this represents improvement from the previous year’s low base rather than return to peak funding levels. According to Inc42’s 2024 survey, 91% of investors express general optimism about 2025 startup funding, though actual deployment patterns suggest selectivity. This could create entry point opportunities if valuations have reset. The companies building NHCX infrastructure as of 2024-2025 could become category leaders if the market matures as projected. But the risk of premature investment before product-market fit is clear remains real.

For hospital and insurance tech leaders, the stakes are different: NHCX integration isn’t optional if the government mandate holds and insurers demand it. The question is whether to build, buy, or partner for capabilities that may become essential to compete and whether to view this as compliance cost or strategic opportunity.

The potential is real. The parallel to UPI is conceptually sound. But whether NHCX will actually spawn unicorns remains to be proven, not assumed.

The window to place early bets is open. Whether it’s actually a gold rush or just an interesting infrastructure project will become clear in the next 24-36 months.

Note: This article draws on verified government data (Ministry of Health and Family Welfare, July 2024), publicly available market research (IMARC Group and Ken Research for RCM market sizing; Tracxn for startup ecosystem data; Digital Health News for H1 2025 healthtech funding; Inc42 Annual Investor Survey 2024 for investor sentiment), and company information (PhonePe). Where specific company metrics (pricing, client counts) are cited, these come from company materials and industry coverage rather than independently audited sources. The UPI comparison is used as an analytical framework to understand potential dynamics, not as a prediction of certain outcomes. All market projections are based on third-party research and subject to significant uncertainty. Market sizing figures represent directional estimates from multiple research firms; specific CAGR calculations vary by methodology.

Industry reports and government announcements through early 2026

All developments above are sourced from:

← All posts